Positron emission tomography scanning in the evaluation of hepatocellular carcinoma
Top Cited Papers
- 1 May 2000
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 32 (5), 792-797
- https://doi.org/10.1016/s0168-8278(00)80248-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- MR imaging during arterial portography for assessment of hepatocellular carcinoma: comparison with CT during arterial portography.American Journal of Roentgenology, 1998
- Limited Value of Fluorine-18-Fluorodeoxyglucose PET for the Differential Diagnosis of Focal Liver Lesions in Patients with Chronic Hepatitis C Virus InfectionNuklearmedizin, 1998
- Correlative imaging of the liver and hepatobiliary systemSeminars in Nuclear Medicine, 1994
- Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.RadioGraphics, 1993
- PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.Radiology, 1992
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- Portal vein involvement in hepatocellular carcinoma: dynamic CT features.Radiology, 1984
- Issues in the in vivo measurement of glucose metabolism of human central nervous system tumorsAnnals of Neurology, 1984
- Glucose utilization of cerebral gliomas measured by [ 18 F] fluorodeoxyglucose and positron emission tomographyNeurology, 1982
- Differential Diagnosis of Hepatic Masses on Computed Tomography, with Particular Reference to Hepatocellular CarcinomaJournal of Computer Assisted Tomography, 1981